The aim is to discuss recent developments in cancer vaccines and how the COVID-19 pandemic has influenced this field.
Analyzed advances in cancer vaccine technology
Reviewed clinical trial results
Examined the role of AI in vaccine development
Explored the use of pandemic infrastructure for vaccine research
Identified successful clinical trial outcomes for cancer vaccines
Highlighted the potential of AI to enhance vaccine design
Demonstrated how COVID-19 frameworks can expedite vaccine deployment
Resumen
This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.